<?xml version="1.0" encoding="UTF-8"?>

<?xml-stylesheet type="text/xsl" href="/static/oaitohtml.xsl"?>

<!--
<?xml-stylesheet type="text/xsl" href="/oaitohtml.xsl"?>
-->

<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <responseDate>2026-10-14T13:49:21Z</responseDate>
    <request verb="GetRecord" metadataPrefix="oai_dc" identifier="10.57760/sciencedb.zhfsyxyfhzz.00012" >https://www.scidb.cn/oai</request>
<GetRecord>
    <record>
    <header >
    <identifier>10.57760/sciencedb.zhfsyxyfhzz.00012</identifier>
    <datestamp>2025-09-15T09:43:15Z</datestamp>
</header>
    <metadata>
        
<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:date>2025-09-15</dc:date>
  <dc:title>Mechanism of Leptin Inhibiting Ferroptosis-Mediated Radioresistance in Triple-Negative Breast Cancer via the LCN2/SLC7A11/GPX4 Pathway</dc:title>
  <dc:identifier>doi:10.57760/sciencedb.zhfsyxyfhzz.00012</dc:identifier>
  <dc:language>en</dc:language>
  <dc:description>Objective:To investigate the role of leptin in regulating ferroptosis-related signaling pathways and its impact on radioresistance in triple-negative breast cancer.Methods: The treatment conditions of leptin were optimized using Western blot analysis and Cell counting kit-8 (CCK-8) assay. Triple-negative breast cancer cell lines MDA-MB-231 and BT-549 were divided into control, leptin, ionizing radiation, and ionizing radiation plus leptin groups. Malondialdehyde (MDA) levels were measured using a microplate reader, while reactive oxygen species (ROS) accumulation and apoptosis were assessed by flow cytometry. Western blot analysis was performed to detect phosphorylated signal transducer and activator of transcription 3 (p-STAT3), solute carrier family 7 member 11 (SLC7A11), and glutathione peroxidase 4 (GPX4). In addition, bioinformatics analysis was applied to screen potential regulatory molecules, and lipocalin 2 (LCN2) expression was validated. The role of LCN2 in leptin-mediated regulation of SLC7A11/GPX4 was further evaluated by siRNA-mediated knockdown, and immunohistochemistry was conducted in breast cancer tissues. Results: Leptin promoted the proliferation of triple-negative breast cancer cells, inhibited apoptosis, reduced MDA and ROS levels, and upregulated SLC7A11 and GPX4, thereby attenuating radiation-induced ferroptosis. Silencing of LCN2 diminished the leptin-induced upregulation of SLC7A11/GPX4, suggesting that LCN2 was a key mediator of leptin-driven ferroptosis suppression. Immunohistochemistry further revealed that breast cancer tissues with high leptin expression exhibited significantly elevated levels of LCN2, SLC7A11, and GPX4.Conclusion: Leptin inhibits ferroptosis through the LCN2/SLC7A11/GPX4 signaling pathway, contributing to radioresistance in triple-negative breast cancer, and may serve as a potential target for ferroptosis-based radiosensitization strategies.</dc:description>
  <dc:subject>Triple-negative breast cancer; Leptin; Ferroptosis; Lipocalin 2; Radioresistance</dc:subject>
  <dc:creator>Xiaoxiao.Liu</dc:creator>
  <dc:creator>Yuchen.Wang</dc:creator>
  <dc:creator>Shangyi.Geng</dc:creator>
  <dc:creator>Yongze.Dang</dc:creator>
  <dc:creator>Xia.Li</dc:creator>
  <dc:creator>Wei.Guo</dc:creator>
  <dc:creator>Yue.Ke</dc:creator>
  <dc:creator>Shupei.Pan</dc:creator>
  <dc:creator>Hongbing.Ma</dc:creator>
  <dc:creator>Xixi.Zhao</dc:creator>
  <dc:rights>RESTRICTED</dc:rights>
  <dc:type>dataset</dc:type>
  <dc:publisher>Science Data Bank</dc:publisher>
</oai_dc:dc>

    </metadata>
</record>
</GetRecord>
</OAI-PMH>